New York, NY -- (SBWIRE) -- 01/06/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Neuralstem, Inc (NYSEMKT:CUR), National Bank of Greece (ADR) (NYSE:NBG), Coronado Biosciences Inc (NASDAQ:CNDO), Globalstar, Inc (OTCMKTS:GSAT)
Neuralstem, Inc (NYSEMKT:CUR) showed a volume of 2.06 million shares by the end of last trade whereas the average volume of the stock remained 870,702.00 shares. The stock opened the session at $2.91 but then moved to $2.97. At that price, the stock showed a negative performance of -6.01%. Neuralstem, Inc. is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs. The Company has developed and maintains a portfolio of patents and patent applications that form base for its research and development efforts in the area of neural stem cell research.
Will CUR Get Buyers Even After The Recent Rally? Find Out Here
National Bank of Greece (ADR) (NYSE:NBG) opened the session at $5.64 and closed the session at $5.65. The stock showed a negative performance of -0.35% in previous trading session. Traded with volume of 2.06 million shares in the prior session and the average volume of the stock remained 3.12 million shares. National Bank of Greece SA (the Bank) is a Greece-based financial institution. It provides a range of financial services including retail and commercial banking, asset management, brokerage, investment banking, insurance and real estate at a global level. Its segments are: Retail Banking, which mainly offers different types of loans, deposits and investment products; Corporate and Investment Banking, which includes financial and investment advisory services, deposit accounts,
Has NBG Found The Bottom And Ready To Gain Momentum? Find Out Here
Coronado Biosciences Inc (NASDAQ:CNDO) opened the session at $2.71 and closed the session at $2.78. The stock showed a negative performance of -4.47% in previous trading session. Traded with volume of 2.04 million shares in the prior session and the average volume of the stock remained 2.48 million shares. Coronado Biosciences, Inc. is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company’s two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases,
Why Should Investors Buy CNDO After the Recent Fall? Just Go Here and Find Out
Globalstar, Inc (OTCMKTS:GSAT) the stock advanced 1.16% and finished the session at $1.74. Traded with volume of 2.04 million shares in the prior session and the average volume of the stock remained 3.85 million shares. The beta of the stock remained 3.07. Globalstar, Inc. (Globalstar) is a provider of mobile voice and data communications services globally via satellite. Globalstar’s satellite communications business, by providing critical mobile communications to the Company's subscribers, serves principally recreation and personal; government; public safety and disaster relief; oil and gas; maritime and fishing; natural resources, mining and forestry; construction; utilities and transportation.
Will GSAT Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)